Filtered by:
52 Programs
-
Year in Review
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances Involving the PI3K/AKT/mTOR Pathway in HR-Positive Metastatic Breast Cancer
-
-
H
-
V
-
H
-
-
H
-
V
-
H
+1 more module
-
-
Nursing Symposium
Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Oral Selective Estrogen Receptor Degraders in Breast Cancer
-
-
B
-
H
-
M
- +1
-
B
-
-
ASCO Satellite 2026
Consensus or Controversy? Documenting and Discussing Investigators’ Approaches to the Use of Oral SERDs and Agents Targeting the PI3K/AKT/mTOR Pathway in Breast Cancer
-
-
E
-
J
-
N
- +2
-
E
-
-
Nursing Symposium
Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Targeting the PI3K/AKT/mTOR Pathway in HR-Positive Metastatic Breast Cancer
-
-
K
-
M
-
R
- +1
-
K
-